NEW YORK (GenomeWeb News) – Scripps Florida Professor Claes Wahlstedt has founded a new firm, called cuRNA, that will develop therapeutics and possibly diagnostic biomarkers based on non-coding RNA technology licensed from the institute.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.